Literature DB >> 26736463

Iron 'ElectriRx' man: Overground stepping in an exoskeleton combined with noninvasive spinal cord stimulation after paralysis.

Parag N Gad, Yury P Gerasimenko, Sharon Zdunowski, Dimitry Sayenko, Piia Haakana, Amanda Turner, Daniel Lu, Roland R Roy, V Reggie Edgerton.   

Abstract

We asked whether coordinated voluntary movement of the lower limbs could be regained in an individual having been completely paralyzed (>4 yr) and completely absent of vision (>15 yr) using a novel strategy - transcutaneous spinal cord stimulation at selected sites over the spinal vertebrae with just one week of training. We also asked whether this stimulation strategy could facilitate stepping assisted by an exoskeleton (EKSO, EKSO Bionics) that is designed so that the subject can voluntarily complement the work being performed by the exoskeleton. We found that spinal cord stimulation enhanced the level of effort that the subject could generate while stepping in the exoskeleton. In addition, stimulation improved the coordination patterns of the lower limb muscles resulting in a more continuous, smooth stepping motion in the exoskeleton. These stepping sessions in the presence of stimulation were accompanied by greater cardiac responses and sweating than could be attained without the stimulation. Based on the data from this case study it appears that there is considerable potential for positive synergistic effects after complete paralysis by combining the overground stepping in an exoskeleton, a novel transcutaneous spinal cord stimulation paradigm, and daily training.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26736463      PMCID: PMC6436552          DOI: 10.1109/EMBC.2015.7318563

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  8 in total

Review 1.  Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular disease.

Authors:  Alicia K Vose; Joseph F Welch; Jayakrishnan Nair; Erica A Dale; Emily J Fox; Gillian D Muir; Randy D Trumbower; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2021-10-09       Impact factor: 5.330

2.  Novel Noninvasive Spinal Neuromodulation Strategy Facilitates Recovery of Stepping after Motor Complete Paraplegia.

Authors:  Ricardo Siu; Edward H Brown; Samineh Mesbah; Federica Gonnelli; Tanvi Pisolkar; V Reggie Edgerton; Alexander V Ovechkin; Yury P Gerasimenko
Journal:  J Clin Med       Date:  2022-06-25       Impact factor: 4.964

3.  Engaging Cervical Spinal Cord Networks to Reenable Volitional Control of Hand Function in Tetraplegic Patients.

Authors:  Daniel C Lu; V Reggie Edgerton; Morteza Modaber; Nicholas AuYong; Erika Morikawa; Sharon Zdunowski; Melanie E Sarino; Majid Sarrafzadeh; Marc R Nuwer; Roland R Roy; Yury Gerasimenko
Journal:  Neurorehabil Neural Repair       Date:  2016-05-18       Impact factor: 3.919

Review 4.  Intrinsic Axonal Growth and the Drive for Regeneration.

Authors:  Kevin J O'Donovan
Journal:  Front Neurosci       Date:  2016-10-27       Impact factor: 4.677

Review 5.  Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation.

Authors:  Max O Krucoff; Shervin Rahimpour; Marc W Slutzky; V Reggie Edgerton; Dennis A Turner
Journal:  Front Neurosci       Date:  2016-12-27       Impact factor: 4.677

Review 6.  Risk management and regulations for lower limb medical exoskeletons: a review.

Authors:  Yongtian He; David Eguren; Trieu Phat Luu; Jose L Contreras-Vidal
Journal:  Med Devices (Auckl)       Date:  2017-05-09

7.  Design and Performance Evaluation of a Wearable Sensing System for Lower-Limb Exoskeleton.

Authors:  Chunfeng Yue; Xichuan Lin; Ximing Zhang; Jing Qiu; Hong Cheng
Journal:  Appl Bionics Biomech       Date:  2018-09-18       Impact factor: 1.781

8.  The Effect of Non-invasive Spinal Cord Stimulation on Anorectal Function in Individuals With Spinal Cord Injury: A Case Series.

Authors:  Evgeniy Kreydin; Hui Zhong; Igor Lavrov; V Reggie Edgerton; Parag Gad
Journal:  Front Neurosci       Date:  2022-02-17       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.